Literature DB >> 22450084

Central extracorporeal life support in pheochromocytoma crisis.

Carlo Banfi1, Francis Juthier, Pierre-Vladimir Ennezat, Timothee de Saint Denis, Bruno Carnaille, Emmanuelle Leteurtre, Alain Prat, André Vincentelli.   

Abstract

Pheochromocytoma is a catecholamine-secreting tumor associated with clinical presentations ranging from paroxysmal hypertension to intractable cardiogenic shock. We report the use of central extracorporeal life support (ECLS) in a young woman admitted to the intensive care unit with cardiogenic shock. Her medical history included neurofibromatosis type I and pheochromocytoma. ECLS was needed because of severe left ventricular failure and inotropic therapy unresponsiveness. ECLS permitted full recovery of left ventricular function. Right adrenelectomy was performed 4 months later. In this case, central ECLS was used to treat pheochromocytoma-induced cardiogenic shock complicated by pulmonary edema.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22450084     DOI: 10.1016/j.athoracsur.2011.09.018

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Mechanical circulatory support such as extracorporeal membrane oxygenation is indicated in phaeochromocytoma crisis with sustained hypotension.

Authors:  Benjamin C Whitelaw; Julia K Prague; Omar G Mustafa
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

2.  Embolisation of pheochromocytoma to stabilise and wean a patient in cardiogenic shock from emergency extracorporeal life support.

Authors:  Helle Vagner; Thomas Morris Hey; Bo Elle; Marianne Kjær Jensen
Journal:  BMJ Case Rep       Date:  2015-03-03

Review 3.  Pheochromocytoma-induced atrial tachycardia leading to cardiogenic shock and cardiac arrest: resolution with atrioventricular node ablation and pacemaker placement.

Authors:  Hassan Shawa; Mandeep Bajaj; Glenn R Cunningham
Journal:  Tex Heart Inst J       Date:  2014-12-01

4.  Highlighting Indication of extracorporeal membrane oxygenation in endocrine emergencies.

Authors:  Anne Chao; Chih-Hsien Wang; Hao-Chun You; Nai-Kwoun Chou; Hsi-Yu Yu; Nai-Hsin Chi; Shu-Chien Huang; I-Hui Wu; Li-Jung Tseng; Ming-Hsien Lin; Yih-Sharng Chen
Journal:  Sci Rep       Date:  2015-08-24       Impact factor: 4.379

5.  Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report.

Authors:  Xiang Zhou; Dawei Liu; Longxiang Su; Yun Long; Wei Du; Qi Miao; Fang Li; Zhengyu Jin; Zhengpei Zeng; Ailun Luo; Yuguang Huang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock.

Authors:  Guillaume Hekimian; Fatima Kharcha; Nicolas Bréchot; Matthieu Schmidt; Cécile Ghander; Guillaume Lebreton; Xavier Girerd; Christophe Tresallet; Jean-Louis Trouillet; Pascal Leprince; Jean Chastre; Alain Combes; Charles-Edouard Luyt
Journal:  Ann Intensive Care       Date:  2016-11-28       Impact factor: 6.925

7.  Phaeochromocytoma crisis: two cases of undiagnosed phaeochromocytoma presenting after elective nonrelated surgical procedures.

Authors:  P C Johnston; J A Silversides; H Wallace; P A Farling; A Hutchinson; S J Hunter; F Eatock; K R Mullan
Journal:  Case Rep Anesthesiol       Date:  2013-10-28

8.  The feasibility of extracorporeal cardiopulmonary resuscitation for patients with active cancer who undergo in-hospital cardiac arrest.

Authors:  Yo Sep Shin; Pil-Je Kang; Youn-Jung Kim; Seung Mok Ryoo; Sung-Ho Jung; Sang-Bum Hong; Won Young Kim
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.